As of April 2025 CorMedix has a market cap of A$0.76 Billion. This makes CorMedix the world's 6721th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$0.76 B | -3.97% |
2024 | A$0.80 B | 164.76% |
2023 | A$0.30 B | 18.16% |
2022 | A$0.25 B | 7.1% |
2021 | A$0.23 B | -23.01% |
2020 | A$0.31 B | 16.35% |
2019 | A$0.26 B | 33.86% |
2018 | A$0.19 B | 362.59% |
2017 | A$43.09 M | -49.77% |
2016 | A$85.8 M | -14.38% |
2015 | A$0.10 B | 91.17% |
2014 | A$52.42 M | 127.07% |
2013 | A$23.08 M | 191.99% |
2012 | A$7.9 M | 151.63% |
2011 | A$3.14 M | -84.63% |
2010 | A$20.44 M |
On Apr 16th, 2025 the market cap of CorMedix was reported to be: